We propose the topical use of R9-SOCS1-KIR (R9 indicates nine arginine residues) for the treatment of both infectious and autoimmune uveitis, based on our findings in cell culture and in mouse models (26, 27). This evidence concerns the gene SOCS1 and autoimmune uveitis.